Crypto Briefing·
AI-driven optimization in drug synthesis accelerates R&D timelines, potentially reducing costs and expediting market entry for pharmaceuticals. The post GPT-5.4 improves Chan-Lam coupling yields in drug discovery appeared first on Crypto Briefing.
Read full articlePramaana will focus on highly sensitive verticals like law, drug discovery, and tax preparation — where errors can be costly and reliability is at a premium.
OpenAI and Molecule.one show how a near-autonomous AI chemist using GPT-5.4 improved a key drug-making reaction, advancing medicinal chemistry research.
Companies are betting on big implications for pharmaceuticals, financial services and crypto. But sceptics worry about hype
The nonprofit consortium is advancing open-source foundation models and software infrastructure for biology and drug discovery. BERKELEY, Calif., June 9, 2026 — OpenFold Consortium, an open science initiative advancing open-source AI […] The post OpenFold Adds 11 Members to Expand Open-Source AI for Drug Discovery appeared first on AIwire.
SAN FRANCISCO, June 4, 2026 — Causaly has announced a collaboration with Microsoft at Microsoft Build 2026 that brings scientific computation and scientific interpretation together into a single, evidence-grounded workflow […] The post Causaly and Microsoft Integrate Scientific Reasoning and Analytics for Drug Discovery appeared first on AIwire.
OpenAI frontier models GPT-5.5 and GPT-5.4, and Codex, the OpenAI coding agent, are now generally available on Amazon Bedrock. Deploy frontier models on Bedrock's high performance inference engine with built-in security, governance, and pay-per-token pricing.
Artificial intelligence is restructuring medicine from the exam room to the lab bench. The companies doing it most consequentially are not just digitizing old workflows — they are replacing the underlying logic of how care gets documented, how drugs get discovered, how patients move through the system, and how clinicians access knowledge. From cardiothoracic imaging to whole-brain […]
Biohub's AI toolkit democratizes drug discovery, enabling smaller biotech firms to innovate and compete, potentially transforming the industry. The post Biohub unveils AI world model for protein biology, aiming to reshape drug discovery appeared first on Crypto Briefing.
